Over 16 years old in this space, a dynamic movement between branded products and generics has marked Vivimed’s journey. Stabilizing itself in institutional sales Vivimed’s next foray was into contract manufacturing leading up to formulations. The entry into this led us into in licensing. Not stopping with this we catalyzed a whole process of focused research and profiling to sell better solutions and chemistry to large pharma players.

Today’s Vivimed combines strong R&D with business judgment and market scoping. Product selection, drug licensing and more are all part of the Vivimed footprint in both regulated and non regulated markets.

A healthier world is the dream of both the users and the manufacturers. In this dream we have a role. By thinking through new ideas and new ways of approaching the business. Infact we believe the challenge lies in conveying to the world new truths in the process of uncovering new drug delivery systems. Our research is currently focused on an anti arthritic drug, anti-wrinkler, an anti oxidant, an anti cancer drug and an anti acne products. Obesity, good health and wellness becoming vital to the society, our R&D has kept its intellect sufficiently engaged in developing anti-obesity and dieting products.

At the core of all this is our ability to synthesize and understand idea driven, innovative chemistry. Many global players both in our Pharma and Specialty chemicals know us for our inimitable strengths in synthetic organic chemistry.

Our teams can successfully rise to the challenge of identifying new products, new drug delivery systems, do all the robust documentation and work diligently towards licensing. There are several active inlicensing engagements that Vivimed caters to today.